The use of recent techniques such as next-generation sequencing (NGS) has defined panels of genetic abnormalities peculiar to MPN (comprising genes such as TP53, SF3B1, SRSF2, TET2, PTPN11, IDH2, EZH2, DNMT3A and others). Here, EZH2 is linked to myeloproliferative disorder.